Literature DB >> 23812351

Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013.

Caitlin E Carter1, Nadine M Benador.   

Abstract

Therapeutic plasma exchange is an extracorporeal treatment modality that removes systemic circulating pathologic factors or replaces absent plasma components and plays a role in many nephrologic conditions. It presents a number of technical challenges in the pediatric population but has become an increasingly common practice in pediatric nephrology over the past several decades. While prospective evidence is often lacking, our increased understanding of the molecular pathogenesis underlying many pediatric renal diseases provides sound reasoning for the use of plasma exchange in treating these conditions. This review will present the currently accepted indications for plasma exchange in children, the technical aspects of the procedure and its potential complications.

Entities:  

Mesh:

Year:  2013        PMID: 23812351     DOI: 10.1007/s00467-013-2479-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  126 in total

1.  Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients.

Authors:  Nancy L Reinsmoen; Chih-Hung Lai; Harald Heidecke; Mark Haas; Kai Cao; Geraldine Ong; Mehrnoush Naim; Qi Wang; James Mirocha; Joseph Kahwaji; Ashley A Vo; Stanley C Jordan; Duska Dragun
Journal:  Transplantation       Date:  2010-12-27       Impact factor: 4.939

Review 2.  A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders.

Authors:  N Besbas; D Karpman; D Landau; C Loirat; W Proesmans; G Remuzzi; G Rizzoni; C M Taylor; N Van de Kar; L B Zimmerhackl
Journal:  Kidney Int       Date:  2006-06-14       Impact factor: 10.612

3.  Eculizumab in the treatment of atypical hemolytic uremic syndrome in infants.

Authors:  Gema Ariceta; Beatriz Arrizabalaga; Mireia Aguirre; Elvira Morteruel; Margarita Lopez-Trascasa
Journal:  Am J Kidney Dis       Date:  2011-12-23       Impact factor: 8.860

4.  ABO-incompatible living-donor kidney transplantation in children.

Authors:  S Shishido; H Asanuma; E Tajima; K Hoshinaga; O Ogawa; A Hasegawa; M Honda; H Nakai
Journal:  Transplantation       Date:  2001-09-27       Impact factor: 4.939

5.  Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches.

Authors:  J M Cecka; A Y Kucheryavaya; N L Reinsmoen; M S Leffell
Journal:  Am J Transplant       Date:  2010-11-29       Impact factor: 8.086

6.  Describing the effectiveness of immunosuppression drugs and apheresis in the treatment of transplant patients.

Authors:  J G Hattersley; M J Chappell; D Zehnder; R M Higgins; N D Evans
Journal:  Comput Methods Programs Biomed       Date:  2012-02-10       Impact factor: 5.428

7.  Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation.

Authors:  Gabriel M Cara Fuentes; Carmen Garcia Meseguer; Antonia Peña Carrion; Marta Melgosa Hijosa; Araceli Garcia-Pose; Angel Alonso Melgar; Mercedes Navarro Torres
Journal:  Pediatr Nephrol       Date:  2009-12-03       Impact factor: 3.714

8.  Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.

Authors:  Anne-Laure Sellier-Leclerc; Veronique Fremeaux-Bacchi; Marie-Agnès Dragon-Durey; Marie-Alice Macher; Patrick Niaudet; Geneviève Guest; Bernard Boudailliez; François Bouissou; Georges Deschenes; Sophie Gie; Michel Tsimaratos; Michel Fischbach; Denis Morin; Hubert Nivet; Corinne Alberti; Chantal Loirat
Journal:  J Am Soc Nephrol       Date:  2007-06-28       Impact factor: 10.121

9.  Rituximab and intravenous immune globulin for desensitization during renal transplantation.

Authors:  Ashley A Vo; Marina Lukovsky; Mieko Toyoda; Jennifer Wang; Nancy L Reinsmoen; Chih-Hung Lai; Alice Peng; Rafael Villicana; Stanley C Jordan
Journal:  N Engl J Med       Date:  2008-07-17       Impact factor: 91.245

10.  Vascular access complications in long-term pediatric hemodialysis patients.

Authors:  Joshua J Zaritsky; Isidro B Salusky; Barbara Gales; Georgina Ramos; James Atkinson; Amelia Allsteadt; Mary L Brandt; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2008-08-19       Impact factor: 3.714

View more
  4 in total

1.  Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units.

Authors:  Fabio Paglialonga; Claus Peter Schmitt; Rukshana Shroff; Karel Vondrak; Christoph Aufricht; Alan Rees Watson; Gema Ariceta; Michael Fischbach; Gunter Klaus; Tuula Holtta; Sevcan A Bakkaloglu; Alexandra Zurowska; Augustina Jankauskiene; Johan Vande Walle; Betti Schaefer; Elizabeth Wright; Roy Connell; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2014-08-20       Impact factor: 3.714

2.  Assessing safety and efficacy of therapeutic plasma exchange in pediatric patients: A single-center experience.

Authors:  Mohit Chowdhry; P J Mutjhukamaravel; Soma Agrawal; Shiva Prasad Gajulapali; Uday Kumar Thakur
Journal:  Asian J Transfus Sci       Date:  2022-05-26

3.  A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS).

Authors:  John Rathbone; Eva Kaltenthaler; Anna Richards; Paul Tappenden; Alice Bessey; Anna Cantrell
Journal:  BMJ Open       Date:  2013-11-04       Impact factor: 2.692

4.  Plasma exchange for paediatric kidney disease-indications and outcomes: a single-centre experience.

Authors:  Sudheer Kumar Reddy; Afsana Jahan; Swasti Chaturvedi; Indira Agarwal
Journal:  Clin Kidney J       Date:  2015-09-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.